213 related articles for article (PubMed ID: 34021046)
41. ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat.
Okamura T; Hashimoto Y; Mori J; Yamaguchi M; Majima S; Senmaru T; Ushigome E; Nakanishi N; Asano M; Yamazaki M; Takakuwa H; Satoh T; Akira S; Hamaguchi M; Fukui M
Front Immunol; 2021; 12():669629. PubMed ID: 34305899
[TBL] [Abstract][Full Text] [Related]
42. Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1.
Spooner CJ; Lesch J; Yan D; Khan AA; Abbas A; Ramirez-Carrozzi V; Zhou M; Soriano R; Eastham-Anderson J; Diehl L; Lee WP; Modrusan Z; Pappu R; Xu M; DeVoss J; Singh H
Nat Immunol; 2013 Dec; 14(12):1229-36. PubMed ID: 24141388
[TBL] [Abstract][Full Text] [Related]
43. Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses.
Moro K; Kabata H; Tanabe M; Koga S; Takeno N; Mochizuki M; Fukunaga K; Asano K; Betsuyaku T; Koyasu S
Nat Immunol; 2016 Jan; 17(1):76-86. PubMed ID: 26595888
[TBL] [Abstract][Full Text] [Related]
44. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
45. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.
Wallrapp A; Riesenfeld SJ; Burkett PR; Abdulnour RE; Nyman J; Dionne D; Hofree M; Cuoco MS; Rodman C; Farouq D; Haas BJ; Tickle TL; Trombetta JJ; Baral P; Klose CSN; Mahlakõiv T; Artis D; Rozenblatt-Rosen O; Chiu IM; Levy BD; Kowalczyk MS; Regev A; Kuchroo VK
Nature; 2017 Sep; 549(7672):351-356. PubMed ID: 28902842
[TBL] [Abstract][Full Text] [Related]
46. Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury.
Cameron GJM; Cautivo KM; Loering S; Jiang SH; Deshpande AV; Foster PS; McKenzie ANJ; Molofsky AB; Hansbro PM; Starkey MR
Front Immunol; 2019; 10():826. PubMed ID: 31057549
[TBL] [Abstract][Full Text] [Related]
47. Tissue signals imprint ILC2 identity with anticipatory function.
Ricardo-Gonzalez RR; Van Dyken SJ; Schneider C; Lee J; Nussbaum JC; Liang HE; Vaka D; Eckalbar WL; Molofsky AB; Erle DJ; Locksley RM
Nat Immunol; 2018 Oct; 19(10):1093-1099. PubMed ID: 30201992
[TBL] [Abstract][Full Text] [Related]
48. Androgen signaling negatively controls group 2 innate lymphoid cells.
Laffont S; Blanquart E; Savignac M; Cénac C; Laverny G; Metzger D; Girard JP; Belz GT; Pelletier L; Seillet C; Guéry JC
J Exp Med; 2017 Jun; 214(6):1581-1592. PubMed ID: 28484078
[TBL] [Abstract][Full Text] [Related]
49. Pulmonary Group 2 Innate Lymphoid Cell Phenotype Is Context Specific: Determining the Effect of Strain, Location, and Stimuli.
Entwistle LJ; Gregory LG; Oliver RA; Branchett WJ; Puttur F; Lloyd CM
Front Immunol; 2019; 10():3114. PubMed ID: 32038635
[TBL] [Abstract][Full Text] [Related]
50. Bcl11b is essential for group 2 innate lymphoid cell development.
Walker JA; Oliphant CJ; Englezakis A; Yu Y; Clare S; Rodewald HR; Belz G; Liu P; Fallon PG; McKenzie AN
J Exp Med; 2015 Jun; 212(6):875-82. PubMed ID: 25964370
[TBL] [Abstract][Full Text] [Related]
51. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
52. Unique Phenotypes of Heart Resident Type 2 Innate Lymphoid Cells.
Deng Y; Wu S; Yang Y; Meng M; Chen X; Chen S; Li L; Gao Y; Cai Y; Imani S; Chen B; Li S; Deng Y; Li X
Front Immunol; 2020; 11():802. PubMed ID: 32431711
[TBL] [Abstract][Full Text] [Related]
53. Type 2 Innate Lymphoid Cells: Protectors in Type 2 Diabetes.
Painter JD; Akbari O
Front Immunol; 2021; 12():727008. PubMed ID: 34489979
[TBL] [Abstract][Full Text] [Related]
54. Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity.
Ricardo-Gonzalez RR; Schneider C; Liao C; Lee J; Liang HE; Locksley RM
J Exp Med; 2020 Apr; 217(4):. PubMed ID: 32031571
[TBL] [Abstract][Full Text] [Related]
55. Tuft-Cell-Derived Leukotrienes Drive Rapid Anti-helminth Immunity in the Small Intestine but Are Dispensable for Anti-protist Immunity.
McGinty JW; Ting HA; Billipp TE; Nadjsombati MS; Khan DM; Barrett NA; Liang HE; Matsumoto I; von Moltke J
Immunity; 2020 Mar; 52(3):528-541.e7. PubMed ID: 32160525
[TBL] [Abstract][Full Text] [Related]
56. IQ motif-containing GTPase-activating protein 1 is essential for the optimal maintenance of lung ILC2s.
Tayama S; Okuyama Y; Phung HT; Asao A; Kobayashi S; Musha T; Machiyama T; Sakurai T; Zhang C; Ushio-Fukai M; Kawabe T; So T; Ishii N
Int Immunol; 2020 Apr; 32(4):233-241. PubMed ID: 31819988
[TBL] [Abstract][Full Text] [Related]
57. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.
Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T
Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554
[TBL] [Abstract][Full Text] [Related]
58. Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance.
Sun J; Zhang Y; Zhang Q; Hu L; Zhao L; Wang H; Yuan Y; Niu H; Wang D; Zhang H; Liu J; Feng X; Su X; Qiu J; Sun J; Xu H; Zhang C; Wang K; Bi Y; Engleman EG; Shen L
Immunity; 2024 Jun; 57(6):1289-1305.e9. PubMed ID: 38772366
[TBL] [Abstract][Full Text] [Related]
59. An ST2-dependent role of bone marrow-derived group 2 innate lymphoid cells in pulmonary fibrosis.
Zhao Y; De Los Santos FG; Wu Z; Liu T; Phan SH
J Pathol; 2018 Aug; 245(4):399-409. PubMed ID: 29722022
[TBL] [Abstract][Full Text] [Related]
60. IgE promotes type 2 innate lymphoid cells in murine food allergy.
Burton OT; Medina Tamayo J; Stranks AJ; Miller S; Koleoglou KJ; Weinberg EO; Oettgen HC
Clin Exp Allergy; 2018 Mar; 48(3):288-296. PubMed ID: 29247574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
